about
Against doctor's orders: the force and limits of personal autonomy in the health care settingInformed consent in embryonic stem cell research: are we following basic principles?A review of the key issues associated with the commercialization of biobanksThe commercialization of university-based research: Balancing risks and benefitsNewspaper coverage of biobanksProfessional regulation: a potentially valuable tool in responding to "stem cell tourism"Research ethics and stem cells: Is it time to re-think current approaches to oversight?Stem cell research, scientific freedom and the commodification concern.Community Pharmacists' Views and Practices Regarding Natural Health Products Sold in Community PharmaciesPharmaceutical care and access to health information decisions involving minors: Characterizing the pharmacist's obligation to the patient.Stem cell research ethics: consensus statement on emerging issues.Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.The stem cell research environment: a patchwork of patchworks.Policy recommendations for addressing privacy challenges associated with cell-based research and interventions.iPS cells: mapping the policy issues.Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process.Reference re assisted human reproduction actand the future of technology-assisted reproduction and embryo research in Canada.The challenge of regulating rapidly changing science: stem cell legislation in Canada.Canada's approach to conflict- of-interest oversight.Patents, commercialization and the Canadian stem cell research community.Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.Human gene editing: revisiting Canadian policy.An investigation of embryo donation, informed consent, and research oversight in Canadian human embryonic stem cell researchChinese newspaper coverage of (unproven) stem cell therapies and their providersScience communication reconsidered
P50
Q24337007-DA1ED10C-59D1-4F73-B0F0-638680E46DFEQ24681024-D76F174B-DFEB-4053-95B9-2B33483C018CQ28554316-49AFFDBD-1105-4A07-AE70-6B4CAD97055AQ28606345-7D975A22-3556-47F9-9D6D-5A0666AF0458Q28654959-AD5D3062-79A6-48FF-A7AC-EF40946A29C2Q34699745-4BA4CF2A-5F0F-4E23-94A4-F42BF7A48ED0Q35006914-860A2122-AD64-421D-96CC-3B313E17FFECQ35634700-E356DD46-E85C-4D58-A5AD-B6BAEB7BEA47Q36142607-2BDE9F00-7906-4E1D-B98C-F86D34B995BAQ36911976-82C5394E-AD5A-4592-9367-F7E012CD7FF5Q36960160-327E42C9-BAEC-4061-A9D2-289E2CC0DAD8Q37313114-FE0E5295-1641-48DB-9B3D-59AC0B845128Q37517375-16DC6F64-0345-457E-AC79-2F469C983200Q37557772-348F0AA2-F105-451B-9904-68EECE1BF733Q37652434-C04F40BF-FD31-45BE-92B5-AFC7F17EE1A4Q38773813-A4D2F350-3389-4C06-90EC-FC4D4FF1EDCEQ39799567-65409835-7FBA-4411-A666-4378A1929F41Q39990291-E42CB713-3360-49AC-8502-D28922736B23Q42424930-F347BEA2-2212-433D-976C-D7A5855162D2Q45215098-205CCAF9-7A44-4C81-94BC-4D65273200B2Q48380662-A611FA4B-36E8-4547-9E14-326231AF54DBQ52737232-295F4BA2-A8D8-4D59-AD53-6C75304D8E2AQ56785670-0347FA62-2536-442F-84E3-C38999C44A00Q56893951-B4F66C93-CA29-434E-8E77-CA8DEE531140Q57699048-590ABE79-02E9-4652-8857-C74D11BFE815
P50
description
onderzoeker
@nl
name
Ubaka Ogbogu
@ast
Ubaka Ogbogu
@en
Ubaka Ogbogu
@es
Ubaka Ogbogu
@nl
Ubaka Ogbogu
@sl
type
label
Ubaka Ogbogu
@ast
Ubaka Ogbogu
@en
Ubaka Ogbogu
@es
Ubaka Ogbogu
@nl
Ubaka Ogbogu
@sl
prefLabel
Ubaka Ogbogu
@ast
Ubaka Ogbogu
@en
Ubaka Ogbogu
@es
Ubaka Ogbogu
@nl
Ubaka Ogbogu
@sl